GRIP1 Human Pre-designed siRNA Set A contains three designed siRNAs for GRIP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRIP2 Human Pre-designed siRNA Set A contains three designed siRNAs for GRIP2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRIPAP1 Human Pre-designed siRNA Set A contains three designed siRNAs for GRIPAP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRK1 Human Pre-designed siRNA Set A contains three designed siRNAs for GRK1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRK2 Human Pre-designed siRNA Set A contains three designed siRNAs for GRK2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRK3 Human Pre-designed siRNA Set A contains three designed siRNAs for GRK3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRK4 Human Pre-designed siRNA Set A contains three designed siRNAs for GRK4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRK5 Human Pre-designed siRNA Set A contains three designed siRNAs for GRK5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRK6 Human Pre-designed siRNA Set A contains three designed siRNAs for GRK6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRK7 Human Pre-designed siRNA Set A contains three designed siRNAs for GRK7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRL-190-21 (compound 5e) is an inhibitor for SARS-Cov-2-Mpro with a Ki of 0.04 nM and exhibits antiviral activity in VeroE6 cells with EC50 of 0.26 μM. GRL-190-21 reduces the infectivity, replication, and cytopathic effect of SARS-CoV-2 without significant toxicity[1].

GRM1 Human Pre-designed siRNA Set A contains three designed siRNAs for GRM1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm1 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Grm1 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm1 Rat Pre-designed siRNA Set A contains three designed siRNAs for Grm1 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRM2 Human Pre-designed siRNA Set A contains three designed siRNAs for GRM2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm2 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Grm2 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm2 Rat Pre-designed siRNA Set A contains three designed siRNAs for Grm2 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRM3 Human Pre-designed siRNA Set A contains three designed siRNAs for GRM3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm3 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Grm3 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm3 Rat Pre-designed siRNA Set A contains three designed siRNAs for Grm3 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRM4 Human Pre-designed siRNA Set A contains three designed siRNAs for GRM4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm4 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Grm4 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm4 Rat Pre-designed siRNA Set A contains three designed siRNAs for Grm4 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRM5 Human Pre-designed siRNA Set A contains three designed siRNAs for GRM5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm5 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Grm5 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm5 Rat Pre-designed siRNA Set A contains three designed siRNAs for Grm5 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRM6 Human Pre-designed siRNA Set A contains three designed siRNAs for GRM6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm6 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Grm6 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm6 Rat Pre-designed siRNA Set A contains three designed siRNAs for Grm6 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRM7 Human Pre-designed siRNA Set A contains three designed siRNAs for GRM7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm7 Mouse Pre-designed siRNA Set A contains three designed siRNAs for Grm7 gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm7 Rat Pre-designed siRNA Set A contains three designed siRNAs for Grm7 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRM8 Human Pre-designed siRNA Set A contains three designed siRNAs for GRM8 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

Grm8 Rat Pre-designed siRNA Set A contains three designed siRNAs for Grm8 gene (Rat), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRN Human Pre-designed siRNA Set A contains three designed siRNAs for GRN gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRP Human Pre-designed siRNA Set A contains three designed siRNAs for GRP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRPEL1 Human Pre-designed siRNA Set A contains three designed siRNAs for GRPEL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRPEL2 Human Pre-designed siRNA Set A contains three designed siRNAs for GRPEL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRPR Human Pre-designed siRNA Set A contains three designed siRNAs for GRPR gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRSF1 Human Pre-designed siRNA Set A contains three designed siRNAs for GRSF1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRTP1 Human Pre-designed siRNA Set A contains three designed siRNAs for GRTP1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GRWD1 Human Pre-designed siRNA Set A contains three designed siRNAs for GRWD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

GS-9191 is the prodrug of the nucleotide analog PMEG. GS-9191 is a topical agent to permeate skin and be metabolized to the active nucleoside triphosphate analog in the epithelial layer. GS-9191 inhibits NA synthesis, arrests cell in S phase, and induces cell apoptosis. GS-9191 can be used for research of human papillomaviruses (HPV) infection[1].